South African child with HIV reaches 8-plus year survival after only 40 weeks of antiretroviral therapy in infancy.
An examination of payer coverage for multiple sclerosis drugs shows variation in how these drugs are covered and in the evidence that payers review to make these decisions.
Peer-reviewed research conducted by the National Pharmaceutical Council (NPC) and the Center for the Evaluation of Value and Risk in Health at Tufts Medical Center over the past 2 years sheds some light on what’s behind discrepancies in coverage decisions from one insurer to the next.
Cancer patient Beth Wallace provides advice to patients with leiomyosarcoma, as well as to women with cancer in general.
So, the initial meet and greet at Mid-Year went well. You have selected the 'perfect' program. Now, it is time to declare that intention in writing.
Current treatment guidelines utilized by healthcare provider organizations and managed care organization insurance coverage policies for growth hormone therapy are reviewed.
Biosimilars for rituximab, trastuzumab, and bevacizumab are currently approved for use in the European Union.
Expert notes significant advances in the treatment of multiple myeloma, large B cell lymphomas, and acute myeloid leukemia, during a presentation at HOPA 2023 Annual Conference.
Ms. Christopher is a freelance writer based in Portland, Ore.
How can you engage patients to adapt healthy behaviors and be adherent? Motivational Interviewing may be the missing piece.
The placement of clinical pharmacists at the nexus of functional pharmacogenomics and in specialty pharmacy care makes good sense.
The editor of the Pharmacy Times Health-System Edition offers pointers on getting as much as you can out of the 2013 ASHP Midyear Clinical Meeting.
Pharmacists have an important role to play in dispelling myths about the use of insulin in effectively treating diabetes.
With new drugs in the pipeline and the impact of updated FDA drug safety policies on colchicine, gout may no longer be inexpensive to treat.
What is being done to address current and projected shortages of community pharmacists?
COVID-19 has not stolen my final year of pharmacy school from me, but rather, has given me once in lifetime learning opportunities unique to this time in my life and in the world.
The authors examined trends in the utilization of prescription opioid medication following introduction of abuse deterrent technology for Oxycontin.
Continuing education activity featured in the March 2018 edition of Pharmacy Times.
Originating from damage within nerve cells themselves, neuropathic pain is often complex, with many treatment challenges.
Do you have an entrepreneurial idea that could be commercialized? This article describes steps to take to develop your business plan.
More than 25% of US patients have not filled a prescription or have reduced their prescribed dose because of high costs.
Merck's Adherence Estimator survey can help health care professionals counsel patients more effectively.
The California Board of Pharmacy has authorized multiple waivers of specific provisions of pharmacy law, several of which have had major implications for pharmacy technicians and their scope of practice.